FI120354B - DNA-polymeraaseja, joilla on modifioitu nukleotidisitoutumiskohta, DNA-sekvensointia varten - Google Patents

DNA-polymeraaseja, joilla on modifioitu nukleotidisitoutumiskohta, DNA-sekvensointia varten Download PDF

Info

Publication number: FI120354B
Authority: FI; Finland
Prior art keywords: dna; dna polymerase; polymerase; polymerases; primer
Prior art date: 1994-10-17

Application number

FI971611A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI971611L (fi

FI971611A0 (fi

Inventor

Stanley Tabor

Charles C Richardson

Original Assignee

Harvard College

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-17

Filing date

1997-04-16

Publication date

2009-09-30

1994-11-10 Priority claimed from US08/337,615 external-priority patent/US5614365A/en

1997-04-16 Application filed by Harvard College filed Critical Harvard College

1997-04-16 Publication of FI971611A0 publication Critical patent/FI971611A0/fi

1997-06-13 Publication of FI971611L publication Critical patent/FI971611L/fi

2009-09-30 Application granted granted Critical

2009-09-30 Publication of FI120354B publication Critical patent/FI120354B/fi

Links

108010014303 DNA-directed DNA polymerase Proteins 0.000 title claims abstract description 376
102000016928 DNA-directed DNA polymerase Human genes 0.000 title claims abstract description 374
238000001712 DNA sequencing Methods 0.000 title claims description 50
108020004414 DNA Proteins 0.000 claims description 183
230000000694 effects Effects 0.000 claims description 101
238000000034 method Methods 0.000 claims description 85
102000004190 Enzymes Human genes 0.000 claims description 72
108090000790 Enzymes Proteins 0.000 claims description 72
238000010348 incorporation Methods 0.000 claims description 68
125000003729 nucleotide group Chemical group 0.000 claims description 60
239000002773 nucleotide Substances 0.000 claims description 54
150000001413 amino acids Chemical class 0.000 claims description 53
238000012163 sequencing technique Methods 0.000 claims description 50
108060002716 Exonuclease Proteins 0.000 claims description 49
102000013165 exonuclease Human genes 0.000 claims description 49
102000053602 DNA Human genes 0.000 claims description 33
108091028043 Nucleic acid sequence Proteins 0.000 claims description 25
150000007523 nucleic acids Chemical class 0.000 claims description 19
239000011777 magnesium Substances 0.000 claims description 17
125000000539 amino acid group Chemical group 0.000 claims description 16
229910052749 magnesium Inorganic materials 0.000 claims description 16
102000039446 nucleic acids Human genes 0.000 claims description 15
108020004707 nucleic acids Proteins 0.000 claims description 15
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 14
102000009609 Pyrophosphatases Human genes 0.000 claims description 12
108010009413 Pyrophosphatases Proteins 0.000 claims description 12
239000002253 acid Substances 0.000 claims description 10
125000003275 alpha amino acid group Chemical group 0.000 claims description 9
241000589499 Thermus thermophilus Species 0.000 claims description 7
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 5
241000193830 Bacillus <bacterium> Species 0.000 claims description 3
241000589500 Thermus aquaticus Species 0.000 claims description 3
239000003153 chemical reaction reagent Substances 0.000 claims description 3
241001122767 Theaceae Species 0.000 claims 1
230000001174 ascending effect Effects 0.000 claims 1
239000003607 modifier Substances 0.000 claims 1
238000010186 staining Methods 0.000 claims 1
239000005546 dideoxynucleotide Substances 0.000 abstract description 73
108090000623 proteins and genes Proteins 0.000 abstract description 15
238000006243 chemical reaction Methods 0.000 description 143
239000013615 primer Substances 0.000 description 135
239000012634 fragment Substances 0.000 description 125
239000000499 gel Substances 0.000 description 74
108010017826 DNA Polymerase I Proteins 0.000 description 56
102000004594 DNA Polymerase I Human genes 0.000 description 56
108010006785 Taq Polymerase Proteins 0.000 description 56
235000001014 amino acid Nutrition 0.000 description 56
238000003556 assay Methods 0.000 description 54
239000002585 base Substances 0.000 description 53
229940024606 amino acid Drugs 0.000 description 52
239000011541 reaction mixture Substances 0.000 description 44
239000000047 product Substances 0.000 description 36
230000006820 DNA synthesis Effects 0.000 description 32
239000000203 mixture Substances 0.000 description 31
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 28
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 26
238000012986 modification Methods 0.000 description 26
230000004048 modification Effects 0.000 description 26
230000035772 mutation Effects 0.000 description 25
OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 24
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
HDRRAMINWIWTNU-NTSWFWBYSA-N [[(2s,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HDRRAMINWIWTNU-NTSWFWBYSA-N 0.000 description 20
238000003786 synthesis reaction Methods 0.000 description 20
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 18
238000004458 analytical method Methods 0.000 description 18
230000007423 decrease Effects 0.000 description 18
238000012360 testing method Methods 0.000 description 18
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 17
230000015572 biosynthetic process Effects 0.000 description 17
URGJWIFLBWJRMF-JGVFFNPUSA-N ddTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 URGJWIFLBWJRMF-JGVFFNPUSA-N 0.000 description 17
239000000243 solution Substances 0.000 description 17
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 16
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 16
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 16
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 15
238000001502 gel electrophoresis Methods 0.000 description 15
230000002209 hydrophobic effect Effects 0.000 description 15
229910052748 manganese Inorganic materials 0.000 description 15
239000011572 manganese Substances 0.000 description 15
241000588724 Escherichia coli Species 0.000 description 14
238000001962 electrophoresis Methods 0.000 description 14
239000011780 sodium chloride Substances 0.000 description 14
150000001768 cations Chemical class 0.000 description 13
XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 13
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 13
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 12
ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical group O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 description 12
239000000872 buffer Substances 0.000 description 12
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 12
108050009160 DNA polymerase 1 Proteins 0.000 description 11
238000012300 Sequence Analysis Methods 0.000 description 11
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 11
230000006870 function Effects 0.000 description 11
238000011534 incubation Methods 0.000 description 11
239000000523 sample Substances 0.000 description 11
239000000758 substrate Substances 0.000 description 11
108020004682 Single-Stranded DNA Proteins 0.000 description 10
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 10
238000010790 dilution Methods 0.000 description 10
239000012895 dilution Substances 0.000 description 10
229920002401 polyacrylamide Polymers 0.000 description 10
229940083575 sodium dodecyl sulfate Drugs 0.000 description 10
235000019333 sodium laurylsulphate Nutrition 0.000 description 10
239000001226 triphosphate Substances 0.000 description 10
108091003079 Bovine Serum Albumin Proteins 0.000 description 9
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
229940098773 bovine serum albumin Drugs 0.000 description 9
230000008859 change Effects 0.000 description 9
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 9
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 9
238000009826 distribution Methods 0.000 description 9
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 9
150000003839 salts Chemical class 0.000 description 9
235000011178 triphosphate Nutrition 0.000 description 9
102000009617 Inorganic Pyrophosphatase Human genes 0.000 description 8
108010009595 Inorganic Pyrophosphatase Proteins 0.000 description 8
229920000642 polymer Polymers 0.000 description 8
230000002285 radioactive effect Effects 0.000 description 8
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
102100034343 Integrase Human genes 0.000 description 7
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 7
PUSXDQXVJDGIBK-NKWVEPMBSA-N [(2s,5r)-5-(6-aminopurin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](COP(O)(O)=O)O1 PUSXDQXVJDGIBK-NKWVEPMBSA-N 0.000 description 7
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 7
239000000428 dust Substances 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
230000005764 inhibitory process Effects 0.000 description 7
238000002703 mutagenesis Methods 0.000 description 7
231100000350 mutagenesis Toxicity 0.000 description 7
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
241000589596 Thermus Species 0.000 description 6
238000013459 approach Methods 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 6
125000004122 cyclic group Chemical group 0.000 description 6
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 6
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 6
229910021645 metal ion Inorganic materials 0.000 description 6
230000002829 reductive effect Effects 0.000 description 6
238000012216 screening Methods 0.000 description 6
238000006467 substitution reaction Methods 0.000 description 6
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 5
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
240000004808 Saccharomyces cerevisiae Species 0.000 description 5
238000000246 agarose gel electrophoresis Methods 0.000 description 5
238000000376 autoradiography Methods 0.000 description 5
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 5
238000012217 deletion Methods 0.000 description 5
230000037430 deletion Effects 0.000 description 5
235000011180 diphosphates Nutrition 0.000 description 5
210000003811 finger Anatomy 0.000 description 5
239000007850 fluorescent dye Substances 0.000 description 5
229910001437 manganese ion Inorganic materials 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
-1 nucleoside triphosphate Chemical class 0.000 description 5
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 5
229940048084 pyrophosphate Drugs 0.000 description 5
239000000126 substance Substances 0.000 description 5
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 5
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
239000004475 Arginine Substances 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
101710116281 Gene 5 protein Proteins 0.000 description 4
108091034117 Oligonucleotide Proteins 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
101000902592 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) DNA polymerase Proteins 0.000 description 4
101710137500 T7 RNA polymerase Proteins 0.000 description 4
102000002933 Thioredoxin Human genes 0.000 description 4
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
229910052742 iron Inorganic materials 0.000 description 4
238000011068 loading method Methods 0.000 description 4
230000007935 neutral effect Effects 0.000 description 4
235000018102 proteins Nutrition 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
238000000746 purification Methods 0.000 description 4
239000011535 reaction buffer Substances 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
238000005476 soldering Methods 0.000 description 4
108060008226 thioredoxin Proteins 0.000 description 4
229940094937 thioredoxin Drugs 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
108010076499 DNA polymerase X Proteins 0.000 description 3
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
239000004471 Glycine Substances 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
108010021466 Mutant Proteins Proteins 0.000 description 3
102000008300 Mutant Proteins Human genes 0.000 description 3
101100117496 Sulfurisphaera ohwakuensis pol-alpha gene Proteins 0.000 description 3
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 3
235000009582 asparagine Nutrition 0.000 description 3
229960001230 asparagine Drugs 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000003197 catalytic effect Effects 0.000 description 3
230000000295 complement effect Effects 0.000 description 3
238000007796 conventional method Methods 0.000 description 3
239000013078 crystal Substances 0.000 description 3
238000013016 damping Methods 0.000 description 3
KHWCHTKSEGGWEX-UHFFFAOYSA-N deoxyadenylic acid Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(O)=O)O1 KHWCHTKSEGGWEX-UHFFFAOYSA-N 0.000 description 3
230000001066 destructive effect Effects 0.000 description 3
238000001514 detection method Methods 0.000 description 3
239000000975 dye Substances 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
239000011737 fluorine Substances 0.000 description 3
229910052731 fluorine Inorganic materials 0.000 description 3
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
235000004554 glutamine Nutrition 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
150000002500 ions Chemical class 0.000 description 3
238000002372 labelling Methods 0.000 description 3
238000000329 molecular dynamics simulation Methods 0.000 description 3
239000002777 nucleoside Substances 0.000 description 3
238000006116 polymerization reaction Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000008569 process Effects 0.000 description 3
125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
230000007306 turnover Effects 0.000 description 3
LTFMZDNNPPEQNG-KVQBGUIXSA-N 2'-deoxyguanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 LTFMZDNNPPEQNG-KVQBGUIXSA-N 0.000 description 2
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 2
101000909256 Caldicellulosiruptor bescii (strain ATCC BAA-1888 / DSM 6725 / Z-1320) DNA polymerase I Proteins 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
101900297506 Human immunodeficiency virus type 1 group M subtype B Reverse transcriptase/ribonuclease H Proteins 0.000 description 2
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
108020005196 Mitochondrial DNA Proteins 0.000 description 2
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
241000205188 Thermococcus Species 0.000 description 2
101000865057 Thermococcus litoralis DNA polymerase Proteins 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
235000003704 aspartic acid Nutrition 0.000 description 2
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
238000006555 catalytic reaction Methods 0.000 description 2
239000002738 chelating agent Substances 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
230000001351 cycling effect Effects 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
LTFMZDNNPPEQNG-UHFFFAOYSA-N deoxyguanylic acid Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1CC(O)C(COP(O)(O)=O)O1 LTFMZDNNPPEQNG-UHFFFAOYSA-N 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000000688 desorption electrospray ionisation Methods 0.000 description 2
230000029087 digestion Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000011067 equilibration Methods 0.000 description 2
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
238000000605 extraction Methods 0.000 description 2
238000001917 fluorescence detection Methods 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
238000003384 imaging method Methods 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
238000004255 ion exchange chromatography Methods 0.000 description 2
229910001425 magnesium ion Inorganic materials 0.000 description 2
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
238000012856 packing Methods 0.000 description 2
239000008188 pellet Substances 0.000 description 2
XUYJLQHKOGNDPB-UHFFFAOYSA-N phosphonoacetic acid Chemical compound OC(=O)CP(O)(O)=O XUYJLQHKOGNDPB-UHFFFAOYSA-N 0.000 description 2
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
238000004153 renaturation Methods 0.000 description 2
241000894007 species Species 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
239000007858 starting material Substances 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
CROYZNIEESCKGY-UHFFFAOYSA-N 1-(5-methoxy-4-methyl-2-methylsulfanylphenyl)propan-2-amine Chemical compound COC1=CC(CC(C)N)=C(SC)C=C1C CROYZNIEESCKGY-UHFFFAOYSA-N 0.000 description 1
XKKCQTLDIPIRQD-JGVFFNPUSA-N 1-[(2r,5s)-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)CC1 XKKCQTLDIPIRQD-JGVFFNPUSA-N 0.000 description 1
WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
OIWXLVBZDMAARO-UHFFFAOYSA-N 2-decylsulfanylethanamine Chemical compound CCCCCCCCCCSCCN OIWXLVBZDMAARO-UHFFFAOYSA-N 0.000 description 1
ZTLXICJMNFREPA-UHFFFAOYSA-N 3,3,6,6,9,9-hexamethyl-1,2,4,5,7,8-hexaoxonane Chemical compound CC1(C)OOC(C)(C)OOC(C)(C)OO1 ZTLXICJMNFREPA-UHFFFAOYSA-N 0.000 description 1
101150007523 32 gene Proteins 0.000 description 1
101150031143 46 gene Proteins 0.000 description 1
101150046633 77 gene Proteins 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
241000702014 Bacillus phage SPO2 Species 0.000 description 1
241000702194 Bacillus virus SPO1 Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
235000021538 Chard Nutrition 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
241001478240 Coccus Species 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
101000746263 Conus leopardus Conotoxin Lp5.1 Proteins 0.000 description 1
101710139375 Corneodesmosin Proteins 0.000 description 1
CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
108010071146 DNA Polymerase III Proteins 0.000 description 1
102000007528 DNA Polymerase III Human genes 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
241000701832 Enterobacteria phage T3 Species 0.000 description 1
241001524679 Escherichia virus M13 Species 0.000 description 1
241000701988 Escherichia virus T5 Species 0.000 description 1
102220585397 Fibroblast growth factor receptor 1_Y766F_mutation Human genes 0.000 description 1
108010078851 HIV Reverse Transcriptase Proteins 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
101000854908 Homo sapiens WD repeat-containing protein 11 Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
108010015268 Integration Host Factors Proteins 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
241000406668 Loxodonta cyclotis Species 0.000 description 1
108060004795 Methyltransferase Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
108010002747 Pfu DNA polymerase Proteins 0.000 description 1
108010010677 Phosphodiesterase I Proteins 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
239000004365 Protease Substances 0.000 description 1
241000205160 Pyrococcus Species 0.000 description 1
108091028733 RNTP Proteins 0.000 description 1
101710114792 Repair DNA polymerase X Proteins 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
241000277331 Salmonidae Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
101900233756 Streptococcus pneumoniae DNA polymerase I Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
241000205091 Sulfolobus solfataricus Species 0.000 description 1
101100388071 Thermococcus sp. (strain GE8) pol gene Proteins 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108010001244 Tli polymerase Proteins 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
102100020705 WD repeat-containing protein 11 Human genes 0.000 description 1
238000002441 X-ray diffraction Methods 0.000 description 1
229960004150 aciclovir Drugs 0.000 description 1
MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
239000008272 agar Substances 0.000 description 1
239000003513 alkali Substances 0.000 description 1
239000000956 alloy Substances 0.000 description 1
229910045601 alloy Inorganic materials 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
FQCKMBLVYCEXJB-MNSAWQCASA-L atorvastatin calcium Chemical compound [Ca+2].C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1.C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 FQCKMBLVYCEXJB-MNSAWQCASA-L 0.000 description 1
238000002314 autoradiolysis reaction Methods 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
229910052790 beryllium Inorganic materials 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
244000309466 calf Species 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000010367 cloning Methods 0.000 description 1
230000008045 co-localization Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
125000000086 dCMP group Chemical group 0.000 description 1
125000003791 dGMP group Chemical group 0.000 description 1
UFJPAQSLHAGEBL-RRKCRQDMSA-N dITP Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(N=CNC2=O)=C2N=C1 UFJPAQSLHAGEBL-RRKCRQDMSA-N 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
239000005549 deoxyribonucleoside Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
230000001036 exonucleolytic effect Effects 0.000 description 1
238000013213 extrapolation Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000001215 fluorescent labelling Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
229960002963 ganciclovir Drugs 0.000 description 1
IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
238000007429 general method Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
229960002743 glutamine Drugs 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
102000040430 polynucleotide Human genes 0.000 description 1
108091033319 polynucleotide Proteins 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
235000011056 potassium acetate Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
229960003581 pyridoxal Drugs 0.000 description 1
235000008164 pyridoxal Nutrition 0.000 description 1
239000011674 pyridoxal Substances 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
102220230270 rs144016984 Human genes 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000007423 screening assay Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229960001153 serine Drugs 0.000 description 1
235000004400 serine Nutrition 0.000 description 1
238000004557 single molecule detection Methods 0.000 description 1
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
229940048086 sodium pyrophosphate Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
210000003813 thumb Anatomy 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
230000007704 transition Effects 0.000 description 1
238000010396 two-hybrid screening Methods 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
239000004474 valine Substances 0.000 description 1
229960003636 vidarabine Drugs 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
NLIVDORGVGAOOJ-MAHBNPEESA-M xylene cyanol Chemical compound [Na+].C1=C(C)C(NCC)=CC=C1C(\C=1C(=CC(OS([O-])=O)=CC=1)OS([O-])=O)=C\1C=C(C)\C(=[NH+]/CC)\C=C/1 NLIVDORGVGAOOJ-MAHBNPEESA-M 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)
Saccharide Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

FI971611A 1994-10-17 1997-04-16 DNA-polymeraaseja, joilla on modifioitu nukleotidisitoutumiskohta, DNA-sekvensointia varten FI120354B (fi)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US32443794A	1994-10-17	1994-10-17
US32443794		1994-10-17
US08/337,615 US5614365A (en)	1994-10-17	1994-11-10	DNA polymerase having modified nucleotide binding site for DNA sequencing
US33761594		1994-11-10
US9512928		1995-10-16
PCT/US1995/012928 WO1996012042A2 (en)	1994-10-17	1995-10-16	Dna polymerases having modified nucleotide binding site for dna sequencing

Publications (3)

Publication Number	Publication Date
FI971611A0 FI971611A0 (fi)	1997-04-16
FI971611L FI971611L (fi)	1997-06-13
FI120354B true FI120354B (fi)	2009-09-30

Family

ID=26984456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI971611A FI120354B (fi)	1994-10-17	1997-04-16	DNA-polymeraaseja, joilla on modifioitu nukleotidisitoutumiskohta, DNA-sekvensointia varten

Country Status (12)

Country	Link
EP (1)	EP0655506B1 (de)
CN (1)	CN100335621C (de)
AT (1)	ATE143057T1 (de)
AU (1)	AU4193396A (de)
CA (1)	CA2201885C (de)
DE (2)	DE655506T1 (de)
DK (1)	DK0655506T3 (de)
ES (1)	ES2072238T3 (de)
FI (1)	FI120354B (de)
GR (1)	GR950300040T1 (de)
HU (1)	HU220839B1 (de)
WO (1)	WO1996012042A2 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5912155A (en) *	1994-09-30	1999-06-15	Life Technologies, Inc.	Cloned DNA polymerases from Thermotoga neapolitana
US6015668A (en) *	1994-09-30	2000-01-18	Life Technologies, Inc.	Cloned DNA polymerases from thermotoga and mutants thereof
JP3966555B2 (ja) *	1995-05-31	2007-08-29	ジーイー・ヘルスケア・バイオサイエンス・コーポレイション	熱耐性ｄｎａポリメラーゼ
US6077664A (en) *	1995-06-07	2000-06-20	Promega Corporation	Thermophilic DNA polymerases from Thermotoga neapolitana
US6001645A (en) *	1995-06-07	1999-12-14	Promega Corporation	Thermophilic DNA polymerases from thermotoga neapolitana
US5773258A (en) *	1995-08-25	1998-06-30	Roche Molecular Systems, Inc.	Nucleic acid amplification using a reversibly inactivated thermostable enzyme
US5948614A (en) *	1995-09-08	1999-09-07	Life Technologies, Inc.	Cloned DNA polymerases from thermotoga maritima and mutants thereof
GB9524974D0 (en) *	1995-12-06	1996-02-07	Amersham Int Plc	An improved method for dye-terminator (cycle) sequencing
US5744312A (en) *	1995-12-15	1998-04-28	Amersham Life Science, Inc.	Thermostable DNA polymerase from Thermoanaerobacter thermohydrosulfuricus
US5888736A (en) *	1995-12-22	1999-03-30	Visible Genetics, Inc.	Method, compositions and kit for detection and identification of microorganisms
US5830657A (en) *	1996-05-01	1998-11-03	Visible Genetics Inc.	Method for single-tube sequencing of nucleic acid polymers
US5789168A (en) *	1996-05-01	1998-08-04	Visible Genetics Inc.	Method for amplification and sequencing of nucleic acid polymers
DE19612684A1 (de) *	1996-03-29	1997-10-02	Gsf Forschungszentrum Umwelt	Neue Verwendung extrem thermophiler DNA-Polymerasen
US6413718B1 (en)	1996-05-01	2002-07-02	Visible Genetics Inc.	Method for sequencing of nucleic acid polymers
US6083699A (en) *	1996-05-01	2000-07-04	Visible Genetics Inc.	Method for bi-directional sequencing of nucleic acid polymers
EP0896632B1 (de) *	1996-05-01	2001-12-12	Visible Genetics Inc.	Verfahren zum nachweis und zur identifizierung von mikroorganismen
US6214555B1 (en)	1996-05-01	2001-04-10	Visible Genetics Inc.	Method compositions and kit for detection
US5827716A (en) *	1996-07-30	1998-10-27	Amersham Life Science, Inc.	Modified Pol-II type DNA polymerases
CZ293215B6 (cs) *	1996-08-06	2004-03-17	F. Hoffmann-La Roche Ag	Rekombinantní tepelně stálá DNA polymeráza, způsob její přípravy a prostředek, který ji obsahuje
US6395524B2 (en)	1996-11-27	2002-05-28	University Of Washington	Thermostable polymerases having altered fidelity and method of identifying and using same
US6306588B1 (en)	1997-02-07	2001-10-23	Invitrogen Corporation	Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
CA2283789C (en)	1997-03-12	2005-07-05	The Perkin-Elmer Corporation	Dna polymerases having improved labeled nucleotide incorporation properties
JP3172710B2 (ja)	1997-07-07	2001-06-04	理化学研究所	Ｒｎａポリメラーゼ
JP3318579B2 (ja)	1997-07-07	2002-08-26	理化学研究所	Ｄｎａの塩基配列決定方法
US6228628B1 (en) *	1997-07-09	2001-05-08	Roche Molecular Systems	Mutant chimeric DNA polymerase
US5882904A (en) *	1997-08-04	1999-03-16	Amersham Pharmacia Biotech Inc.	Thermococcus barossii DNA polymerase mutants
US6346379B1 (en)	1997-09-11	2002-02-12	F. Hoffman-La Roche Ag	Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescein family dyes
EP1071812A4 (de) *	1998-01-23	2002-05-15	Amersham Pharm Biotech Inc	Methode, reagenzlösung und kits zur dna-sequenzierung
CA2266755A1 (en) *	1998-04-24	1999-10-24	James M. Dunn	Method for sequencing of nucleic acid polymers
US6096875A (en)	1998-05-29	2000-08-01	The Perlein-Elmer Corporation	Nucleotide compounds including a rigid linker
GB9907813D0 (en) *	1999-04-06	1999-06-02	Medical Biosystems Ltd	Synthesis
AU6768700A (en) *	1999-08-21	2001-03-19	Amersham Pharmacia Biotech Inc.	Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance
US20040009486A1 (en)	1999-10-29	2004-01-15	Sorge Joseph A.	Compositions and methods utilizing DNA polymerases
AU1239901A (en) *	1999-10-29	2001-05-14	Stratagene	Compositions and methods utilizing dna polymerases
EP1232270A1 (de)	1999-11-23	2002-08-21	Amersham Biosciences Corp.	Verbesserter dideoxynucleotidtriphosphatverbrauch durch hyperthermophile dna polymerase aus dem archaebakterium i(pyrococcus furiosus)
US6329178B1 (en) *	2000-01-14	2001-12-11	University Of Washington	DNA polymerase mutant having one or more mutations in the active site
US7179590B2 (en)	2000-04-18	2007-02-20	Roche Molecular Systems, Inc	High temperature reverse transcription using mutant DNA polymerases
AU2007201277B2 (en) *	2000-05-24	2011-10-13	Third Wave Technologies, Inc.	Detection of RNA
US7198924B2 (en)	2000-12-11	2007-04-03	Invitrogen Corporation	Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US20050042629A1 (en)	2002-09-13	2005-02-24	Applera Corporation	Thermus scotoductus nucleic acid polymerases
US7222059B2 (en)	2001-11-15	2007-05-22	Siemens Medical Solutions Diagnostics	Electrophoretic trace simulator
AU2002346517A1 (en) *	2001-11-30	2003-06-17	Applera Corporation	Thermus oshimai nucleic acid polymerases
AU2002352902A1 (en) *	2001-11-30	2003-06-17	Applera Corporation	Thermus thermophilus nucleic acid polymerases
WO2003048308A2 (en)	2001-11-30	2003-06-12	Applera Corporation	Thermus brockianus nucleic acid polymerases
CA2485203A1 (en) *	2002-05-31	2003-12-11	University Of Washington	Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants
US7309570B2 (en)	2002-10-21	2007-12-18	University Of Texas	Methods for using double-mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
EP1697534B1 (de)	2003-12-01	2010-06-02	Life Technologies Corporation	Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
US20070259339A1 (en)	2005-12-23	2007-11-08	James Hnatyszyn	Methods and reagents for genotyping hcv
EP2013366B1 (de)	2006-05-01	2016-11-30	Siemens Healthcare Diagnostics Inc.	Sequenzierung vom L10-Codon vom HIV-gag-Gen
EP3172332B1 (de) *	2014-07-22	2020-10-14	Bio-rad Laboratories, Inc.	Puffer zur verwendung mit polymerasen
CN106318924B (zh) *	2016-10-26	2018-10-16	江南大学	一种催化dna合成延伸能力提高的dna聚合酶
CN109652499B (zh) *	2017-10-12	2022-06-03	深圳华大智造科技股份有限公司	快速检测dna聚合酶3′-5′外切活性或错配的方法和试剂盒
CN110093410A (zh) *	2019-05-21	2019-08-06	通用生物系统（安徽）有限公司	一种dna测序反应试剂及其制备方法
CN119506241A (zh) *	2019-11-13	2025-02-25	深圳市真迈生物科技有限公司	改造的Klenow片段及应用
CN111826366B (zh) *	2020-06-05	2022-08-02	广州英赞生物科技有限公司	一种直扩型热启动dna聚合酶及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1338457C (en) *	1986-08-22	1996-07-16	Henry A. Erlich	Purified thermostable enzyme
US4942130A (en) *	1987-01-14	1990-07-17	President & Fellows Of Harvard College	T7 DNA polymerase
US4962020A (en) *	1988-07-12	1990-10-09	President And Fellows Of Harvard College	DNA sequencing
WO1990008839A1 (en) *	1989-02-06	1990-08-09	Eastman Kodak Company	Thermostable polymerase dna sequencing reaction concentrate
US5001050A (en) *	1989-03-24	1991-03-19	Consejo Superior Investigaciones Cientificas	PHφ29 DNA polymerase
US5108892A (en) *	1989-08-03	1992-04-28	Promega Corporation	Method of using a taq dna polymerase without 5'-3'-exonuclease activity
WO1993002212A1 (en) *	1991-07-24	1993-02-04	University Partnerships Pty. Ltd.	Single step amplification and sequencing of nucleic acids

1994
- 1994-11-24 DE DE0655506T patent/DE655506T1/de active Pending
- 1994-11-24 AT AT94203433T patent/ATE143057T1/de active
- 1994-11-24 EP EP94203433A patent/EP0655506B1/de not_active Expired - Lifetime
- 1994-11-24 DE DE69400567T patent/DE69400567T2/de not_active Expired - Lifetime
- 1994-11-24 ES ES94203433T patent/ES2072238T3/es not_active Expired - Lifetime
- 1994-11-24 DK DK94203433.1T patent/DK0655506T3/da active
1995
- 1995-07-31 GR GR950300040T patent/GR950300040T1/el unknown
- 1995-10-16 AU AU41933/96A patent/AU4193396A/en not_active Abandoned
- 1995-10-16 WO PCT/US1995/012928 patent/WO1996012042A2/en active IP Right Grant
- 1995-10-16 CN CNB951968297A patent/CN100335621C/zh not_active Expired - Lifetime
- 1995-10-16 HU HU9702016A patent/HU220839B1/hu unknown
- 1995-10-16 CA CA002201885A patent/CA2201885C/en not_active Expired - Lifetime
1997
- 1997-04-16 FI FI971611A patent/FI120354B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO1996012042A3 (en)	1996-08-01
DK0655506T3 (da)	1997-03-10
CN100335621C (zh)	2007-09-05
ES2072238T1 (es)	1995-07-16
FI971611L (fi)	1997-06-13
ATE143057T1 (de)	1996-10-15
EP0655506B1 (de)	1996-09-18
DE655506T1 (de)	1995-09-28
HU220839B1 (en)	2002-06-29
WO1996012042A2 (en)	1996-04-25
DE69400567D1 (de)	1996-10-24
FI971611A0 (fi)	1997-04-16
ES2072238T3 (es)	1997-01-16
GR950300040T1 (en)	1995-07-31
CA2201885A1 (en)	1996-04-25
DE69400567T2 (de)	1997-02-06
CA2201885C (en)	2009-12-29
EP0655506A1 (de)	1995-05-31
HUT77037A (hu)	1998-03-02
AU4193396A (en)	1996-05-06
CN1170439A (zh)	1998-01-14

Publication	Publication Date	Title
FI120354B (fi)	2009-09-30	DNA-polymeraaseja, joilla on modifioitu nukleotidisitoutumiskohta, DNA-sekvensointia varten
EP0727496B1 (de)	2009-08-26	DNS Polymerasen
WO1996012042A9 (en)	1996-10-10	Dna polymerases having modified nucleotide binding site for dna sequencing
JP3170229B2 (ja)	2001-05-28	変性された熱安定性ｄｎａポリメラーゼ
JP5106416B2 (ja)	2012-12-26	濃縮（ｐａｃｋｅｄ）ＤＮＡポリメラーゼを含む核酸複製のための反応緩衝液組成物
US6333159B1 (en)	2001-12-25	Cold sensitive mutant DNA polymerases and methods of use thereof
US5210015A (en)	1993-05-11	Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5849487A (en)	1998-12-15	Nucleic acid detection by repetitive synthesis and degradation of a nucleotide on a nuclease resistant oligonucleotide
US6485909B1 (en)	2002-11-26	DNA polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides
MXPA97005961A (en)	1998-02-01	Thermostable dna polymerase, modification
JP3112148B2 (ja)	2000-11-27	核酸の増幅方法およびその試薬
AU2001266726A1 (en)	2002-03-07	Cold sensitive mutant DNA polymerases
Lehman	1981	2 DNA Polymerase I of Escherichia coli
KR100484124B1 (ko)	2005-09-08	변형된 뉴클레오티드 결합부위를 갖는 dna 서열화용 dna 폴리머라제
KR102286025B1 (ko)	2021-08-05	유전자 변이 특이성이 증가된 dna 중합효소를 이용한 질량분석법
JP2005517413A (ja)	2005-06-16	ポリメラーゼ組成物
JP2000023687A (ja)	2000-01-25	熱安定性ｄｎａポリメラ―ゼ
JP2000354496A (ja)	2000-12-26	核酸の増幅方法およびその試薬

Legal Events

Date	Code	Title	Description
2009-09-30	FG	Patent granted	Ref document number: 120354 Country of ref document: FI
2015-11-18	MA	Patent expired

Date

Code

Title

Description